|
Congressional:
House Passes SUPPORT for Patients and Communities Reauthorization Act of 2025
On Wednesday, the House passed the SUPPORT for Patients and Communities Reauthorization Act of 2025 in a 366-57 vote. The bill would reauthorize bipartisan legislation to prevent and treat illicit opioid use. It would build on the original legislation Congress passed in 2018, which Congress has continued to fund despite it lapsing nearly two years ago. Democrats raised concerns about the Trump administration’s proposed funding cuts for substance use disorder and mental health programs and criticized Republicans’ proposed Medicaid changes, which they said could undermine addiction treatment. The legislation now heads to the Senate. Read the bill here.
Senate Confirms O'Neill For Deputy HHS Secretary
On Thursday, the Senate confirmed James O'Neill to be the Department of Health and Human Services (HHS) Deputy Secretary in a 52-43 vote. O'Neill held several roles at HHS during the Bush administration, including principal associate deputy secretary, associate deputy secretary, and senior adviser to the deputy secretary. O’Neill also previously ran the SENS Research Foundation, a regenerative medicine nonprofit.
CBO Estimated Effects on the Number of Uninsured People in 2034 Resulting from Policies Incorporated Within CBO’s Baseline Projections and the One Big Beautiful Bill Act
On Wednesday, the Congressional Budget Office (CBO) released a letter to the Senator Ron Wyden (D-OR), and Representatives Frank Pallone, Jr. (D-NJ) and Richard Neal (D-MA) concerning the estimated effects on the number of uninsured people in 2034 resulting from policies incorporated within CBO’s baseline projections and the House-passed Republican reconciliation bill, the One Big Beautiful Bill Act. The CBO reported that the legislation, combined with the expiration of the Advance Premium Tax Credit (APTC) and stricter eligibility requirements for the health marketplaces expected to take effect, would increase the number of uninsured by 16 million at the end of 10 years. Of the 16 million, the co-implementation of a proposed Trump administration marketplace rule, combined with the expected expiration of APTCs, would lead to 5.1 million uninsured, and the reforms combined in the reconciliation package would raise the uninsured population by 10.9 million. House Speaker Mike Johnson (R-LA) responded to the report, telling reporters, “These assumptions are wrong. We are not cutting Medicaid.”
The CBO also released on Wednesday the estimated budgetary effects of the One Big Beautiful Bill Act. The estimate found that the House Energy and Commerce Committee exceeded its $880 billion savings goal, with the committee’s cuts totaling $1.1 trillion in savings over the next 10 years, most of which comes from health care. The most significant Medicaid savings come from work requirements in the program: $344 billion, up from a previous estimate of $301 billion after Republicans moved up implementation of employment mandates by two years to 2026. Freezing the provider taxes states use to help finance their programs is also estimated to save $89 billion. The CBO report found that overall, the bill would add $2.4 trillion to the federal deficit over a decade. Read the CBO letter here and the cost estimates here.
Agriculture, Rural Development, FDA Appropriations Bill Proposes FDA Budget Cut
On Wednesday, the House Appropriations Subcommittee on Agriculture, Rural Development and Food and Drug Administration released its fiscal 2026 spending bill, which provides a total discretionary allocation of $25.523 billion: $1.163 billion (4.2%) below the Fiscal Year 2025 enacted level. The Food and Drug Administration (FDA) funding levels would be reduced by $200 million, appropriating $6.8 billion to the agency, with an unspecified amount of that offset by fees. The bill would allocate $2.3 billion to the Center for Drug Evaluation and Research, with a requirement that at least $10 million be spent on pilot programs to increase unannounced foreign inspections. About $550 million would be allocated to the Center for Biologics Evaluation and Research, and about $860 million to the Center for Devices and Radiological Health. Regarding tobacco, the bill allocates $684 million for the Center for Tobacco Products, while $712 million would be collected under the tobacco user fee program. The legislation would also prohibit covered agencies from transferring funding, eliminating a program, reorganizing or relocating offices, or contracting out functions previously served by federal workers unless department heads notify and receive approval from congressional appropriators. On Thursday, the subcommittee voted to advance the bill in a 9-7 party-line vote. Read the bill here and the bill summary here.
Senate HELP Committee Holds Hearing on Reauthorizing FDA Over-The-Counter Drug Program
On Wednesday, the Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing on the reauthorization of the over-the-counter monograph drug user fee program, established under a 2020 COVID-19 relief law. The program allows the FDA to collect user fees from companies to support the agency's oversight of over-the-counter monograph drugs. The legislation outlines how the FDA regulates some over-the-counter drugs that follow a monograph to be recognized as safe and effective without requiring FDA approval before coming to market. The current version of the legislation is set to expire at the end of September if it's not reauthorized. During the hearing, Chair Bill Cassidy (R-LA) urged the Food and Drug Administration (FDA) to speed the process for making prescription drugs available over the counter. Acting Center for Drug Evaluation and Research Director Jacqueline Corrigan-Curay testified at the hearing and faced questions from Cassidy on the agency's process for bringing common prescription medicines to the over-the-counter market. Read more on the hearing here.
Notable Bills Introduced:
Senator Cassidy Reintroduces Legislation to Combat Obesity Epidemic
On Thursday, Senator Bill Cassidy, M.D. (R-LA) reintroduced the Treat and Reduce Obesity Act (TROA) to combat the obesity crisis in the United States by providing regular screenings. The bill would expand coverage of new health care specialists and chronic weight management medications for Medicare recipients. Read the press release here and the bill here.
Senator Rosen Introduces Bipartisan Bills to Expand Access to Palliative Care, Hospice Care
On Thursday, Senator Jacky Rosen (D-NV), co-founder and co-chair of the bipartisan Senate Comprehensive Care Caucus, introduced a pair of bipartisan bills to expand access to palliative and hospice care. The Expanding Access to Palliative Care Act, with Senators Barrasso (R-WY), Baldwin (D-WI), and Fischer (R-NE), would establish a demonstration project through Medicare to expand access to palliative care at the time of diagnosis of serious illness or injury. The Improving Access to Transfusion Care for Hospice Patients Act, with Senators Barrasso (R-WY) and Baldwin (D-WI), would carve out payment for transfusion services within the Medicare hospice benefit, allowing for separate billing to Medicare for transfusions. Read the press release here and the bills here and here.
Representative Pfluger and Senator Cassidy Introduce Bill to Protect Small Biotech Companies
On Wednesday, Representative August Pfluger (R-TX), alongside Senator Bill Cassidy, M.D. (R-LA) and Representative David Kustoff (R-TN), introduced legislation to protect innovative small biotech manufacturers from the Medicare drug price negotiation program. The Small Biotech Innovation Act will establish a new exemption for small biotech companies based on the amount of revenue they reinvest in research and development. Read the press release here and the bill here.
Representatives Wilson, Nadler Reintroduce Bill Providing a Tax Credit to Living Organ Donors
On Tuesday, Representatives Joe Wilson (R-SC) and Jerry Nadler (D-NY) reintroduced the Living Organ Donor Tax Credit Act. The bill will provide a $5,000, one-time, refundable tax credit to living organ donors who were not reimbursed for the costs of organ donation by the National Living Organ Donor Assistance Center (NLDAC), or any other entity. Read the press release here and the bill here.
Executive Branch:
CMS Releases an Informational Bulletin Rescinding Guidance on Adding SOGI Questions to State Medicaid and CHIP Applications for Health Coverage
On Thursday, the Centers for Medicare & Medicaid Services (CMS) released an informational bulletin rescinding Guidance on Adding Sexual Orientation and Gender Identity (SOGI) Questions to State Medicaid and CHIP Applications for Health Coverage. The bulletin states that CMS no longer intends to collect this information from state Medicaid and Children’s Health Insurance Program (CHIP) agencies as part of Transformed Medicaid Statistical Information System (T-MSIS) data submissions. Read the informational bulletin here.
CMS Revokes Biden-Era Rule on Emergency Abortions in Hospitals
On Tuesday, the Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services CMS rescinded guidance put in place by former President Joe Biden that directed US hospitals to provide abortions on an emergency basis when medically necessary to stabilize patients, regardless of state abortion restrictions. The guideline was established in July 2022 under the Emergency Medical Treatment and Labor Act (EMTALA), a law that requires that, for Medicare-funded hospitals, pregnant patients in emergency situations receive appropriate emergency care, including stabilizing treatment, which in some cases could be abortion. In their statement, CMS stated it would continue to enforce the law, “including for identified emergency medical conditions that place the health of a pregnant woman or her unborn child in serious jeopardy,” and would “work to rectify any perceived legal confusion and instability.” Read the press release here.
Director and Deputy Administrator for the Center for Medicaid and CHIP Services Resigns
On Monday, Drew Snyder, Director and Deputy Administrator for the Center for Medicaid and CHIP Services (CMCS), resigned. A CMS spokesperson stated that Snyder, who has led CMCS since late January, is departing the agency purely for “personal family matters,” and the decision is not politically motivated or related to any policy changes at the agency. Dr. Caprice Knapp, the former North Dakota Medicaid director, will be the interim acting director of CMCS. Knapp is currently Medicaid counselor to HHS Secretary Robert F. Kennedy Jr. and was formerly a member of the Congressional Budget Office’s Panel of Health Advisers.
Legal & Other:
Trump Administration Asks Supreme Court to Move Forward with Federal Worker Cuts
On Monday, the Trump administration filed an emergency application with the Supreme Court to move forward with reduction-in-force efforts. In the filing, Solicitor General John Sauer argued that the executive branch has the authority to carry out large-scale employee terminations without Congressional approval. The administration further argued that the terminations have not been fully carried out yet, and that any disputes regarding agency hiring decisions should first go to specialized review boards, not district courts. The application also asserts that the injunction has forced the administration to halt its efforts to cut the federal workforce and is keeping the federal government "bloated" and "inefficient." The emergency application follows an injunction issued on May 22 by Susan Illston, U.S. District Judge for the Northern District of California. Read the filing here.
|